ArticleAdvanced healthcare materials2025
Biomimetic, Suturable, and Extensible Electrospun Scaffolds for Lower Urinary Tract Surgical Reconstruction.
Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Curved by Design: Applying Microfluidic Principles for Nonplanar and Planar Suspended Tissue Patterning to the Development of Bladder Models with Tunable Mechanics.bioRxiv : the preprint server for biology · 2026Article
- Biomimetic, Suturable, and Extensible Electrospun Scaffolds for Lower Urinary Tract Surgical Reconstruction.Advanced healthcare materials · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Common autologous tissue sources used for the repair or replacement of lower urinary tract (LUT) organs include the inner cheek (buccal), small and large bowels, and foreskin. These sources have limited availability, introduce the risk of donor site complications, and differ mechanically and biologically from LUT tissue. To address this, fibrous composite scaffolds with varying ratios of two naturally derived polymers-gelatin methacryloyl and an elastin-like peptide-are fabricated via electrospinning and photo-crosslinking. Among the tested ratios, 5:5% (w/v) elastin-like peptide-gelatin methacryloyl (5E5G) fibrous scaffolds are suturable and most closely replicate LUT tissue, exhibiting a tensile modulus of 25.6 ± 4.77 kPa, an ultimate tensile strength of 41 ± 6.68 kPa, and an elongation of 167.4% ± 5.41%. Furthermore, the 5E5G scaffold exhibits a mean degradation exceeding 50% after 21 days in 37 °C Dulbecco's Phosphate Buffered Saline. In vitro, smooth muscle and fibroblast proliferation is robust on both 0E10G and 5E5G scaffolds, whereas urothelial cells display lower relative proliferation. In vivo subcutaneous implantation in rats demonstrates biocompatibility and supports tissue ingrowth without local fibrosis or inflammatory responses, similar to a sham injury model. Collectively, 5E5G electrospun scaffolds represent promising substrates for enhancing LUT tissue regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.